The Latest Updates on Managing Your Patients With Antimicrobial Resistant Gram-Negative Infections : Episode 2
Impact of 2023 Updated IDSA Guidelines on Antimicrobial Resistant Gram-Negative Infection Treatment
Dr Christian Sandrock evaluates the impact of 2023 updated IDSA guidelines on treatment decisions for patients with antimicrobial resistant gram-negative infections and for patients with multidrug-resistant pathogens.
Video Player is loading.
Recent Videos
AI as a Tool to Support Clinicians, Not Replace Them
Real-Time Adaptive Dosing in Critical Care and How AI Contributes
Bayesian Dosing in Antimicrobial Therapy: Impact on Patient Safety and Hospital Efficiency
Clinical Implications, Study Takeaways of Gepotidacin For Uncomplicated UTIs
Insights from Phase 3 Trial in Burkina Faso on Ivermectin’s Role in Malaria Control
Synthetic Gel Shows Utility Across ABSSSI, Company Sees Other Indications
Phage, Combination Antibiotic Treatment For Resistant Pseudomonas aeruginosa Infection
Gram-Negative Antibiotic Discovery Innovator Initiative to Drive Global Collaboration in Addressing AMR Challenges
2024 S aureus and MRSA Trials: Key Takeaways
Antibiotic Resistance in the Context of UTI Treatment Developments
Related Content
